Online Materials and Methods
Mice. Mice were fed on a normal dry chow diet containing 4.5% fat by weight (0.02% cholesterol), kept on a light/dark (12/12h) cycle at 22°C receiving food and water ad libitum. The diets of mice fed on perhexiline were prepared by homogenising their food and adding the crushed drug Pexsig® (Perhexiline Maleate 100mg, Sigma) in a ratio of 1mg to 1g of mouse food with subsequent freeze-drying of the preparation. All procedures were performed according to protocols approved by the Institutional Committee for the Use and Care of Laboratory Animals. Hearts of C57BL/6 mice used for proteomic and metabolic analyses were rinsed thoroughly with cold PBS to remove any blood components and frozen in liquid nitrogen until they were pulverised with mortar and pestle. Plasma concentrations of perhexiline and hydroxy-perhexiline (OH-perhexiline) were measured by high-performance liquid chromatography (Dr. Alan Hutchinson, Toxicology Lab, LLanduch, UK).
Difference in-gel electrophoresis (DIGE).
Pulverised heart tissue was incubated in 2DE lysis buffer (9.5M urea, 2% w/v CHAPS, 2% v/v Pharmalyte pH 3-10, 1% w/v DTT, protease inhibitors) for 0.5 hr at RT. After centrifugation at 13,000rpm for 15min, the supernatant was collected, proteins were precipitated (2D Clean-up kit, Bio-Rad) and resuspended in DIGE buffer (8M urea, 4% w/v CHAPS, 30mM TrisCl, pH=8.5). Protein concentrations were normalised using the Bradford assay. Samples were labelled with fluorescent dyes Cy3 and Cy5 with Cy2 being reserved for the labelling of the internal standard. Incubation with the dyes was done at a dye/protein ratio of 400pmol/100µg for 30 min on ice with the reaction being quenched with 10mM L-lysine (L8662, Sigma) for 15 min. Samples were mixed in 2x buffer (8M urea, 4% w/v CHAPS, 2% w/v DTT, 2% v/v Pharmalyte pH 3-10) and a volume of sample calculated to have a protein content of 50µg was diluted in rehydration solution (8M urea, 0.5% w/v CHAPS, 0.2% w/v DTT, and 0.2% v/v Pharmalyte pH 3-10) and loaded onto a IPG strip for isoelectric focusing (18cm, pH 3-10NL, GE healthcare) for overnight rehydration. IPG strips were focused overnight for 64.6 kVhrs using a gradient programme at 20°C. Strips were equilibrated and run on top of a 12% SDS gel without stacking gel until the blue dye front reached the end of the gel. Fluorescent images of gels were obtained by scanning with an Ettan DIGE Imager (GE healthcare). Differentially expressed spots showing statistical significance (p<0.05) were filtered by using the DeCyder® software (Version 6.5, GE healthcare). Gels were then silver stained (Plus one silver staining kit, GE healthcare) and spots were excised for analysis by mass spectrometry [1, 2] .
Tandem mass spectrometry. Excised gel spots were subjected to in-gel tryptic digestion with an Investigator ProGest (Genomic Solutions) robotic digestion system with subsequent lyophilisation. Freeze-dried samples were resuspended in 20µl of 0.05% trifluoroacetic acid. Samples were then identified via separation by nano-flow liquid chromatography on a reverse-phase column (PepMap100, 25cm, Dionex) interfaced to a high-performance linear ion trap mass spectrometer (LTQ XL, Thermo Fisher). Spectra were collected for analysis and searched through mouse protein databases using SEQUEST (Bioworks Browser version 3.2, Thermo Fisher Scientifi) and imported into Scaffold software (Proteome software).
Phosphate-affinity gel electrophoresis (Phos-tag TM ).
For phosphate-affinity gel electrophoresis, 50 µg of protein extracts were separated on 10% polyacrylamide gels containing 50 µM Phos-tag TM (Wako Chemicals GmbH) and 50 µM MnCl 2 (Sigma) [1] . After electrophoresis, gels were soaked in transfer buffer with 1mM EDTA for 10 min, then in transfer buffer for another 10 min prior to blotting onto a polyvinylidene fluoride (PVDF) membrane. Membranes were probed with anti-PDH subunit E1 alpha monoclonal antibody (Invitrogen, 459400).
High-resolution NMR spectroscopy. For metabolomic analysis, cardiac metabolites were extracted in 6% perchloric acid [2] . All hearts were from the same litter of mice and harvested and processed at the same time. Storage times of the extracts were identical. Neutralized extracts were freeze-dried and reconstituted in deuterium oxide (D 2 O). One-half milliliter of each extract was placed in 5-mm nuclear magnetic resonance tubes. Proton magnetic resonance spectroscopy ( 1 H-NMR) spectra were obtained using a Bruker 600-MHz spectrometer (Bruker BioSpin GmbH, Rheinstetten, Germany) as previously described [3, 4] . The water resonance was suppressed by using gated irradiation centered on the water frequency. Figure 2C corresponds to a significance level equal to p<0.05. Each resampling was run with a bootstrap sample size of 10,000. Metabolite profiles were interrogated using the context likelihood of relatedness (CLR) between all possible metabolite pairs.
Computational modeling. For computational modeling, we used an existing and well-validated proteome-scale model of heart mitochondria metabolism [9, 10] , slightly modified to address a small earlier error in the mass-balancing of complex IV of the respiratory chain. The model did not contain any kinetic data, but instead consisted of the stoichiometric coefficients of every reaction in the human heart mitochondrial metabolic network, obtained from the existing literature and curated databases [9, 10] . Simulations assumed that the network was at steady-state. In other words, if S was the matrix of stoichiometric coefficients and v was a column vector of unknown reaction fluxes, we sought to characterize all solutions that satisfied S v = 0.
We also applied linear inequalities to many of the elements of v (i.e. upper and lower limits of substrate exchange), based on literature values. Greater detail regarding the model itself can be found in [9, 10] . We chose the mitochondria model for this project because it is small enough to be tractable using random sampling techniques, yet still encompasses the salient features of central carbon metabolism in the human heart. (7)2fad2+2 (7)2h2o2+2 (7)2nad2+2pmtcoa2BB>2 (8)2accoa2+2 (7)2fadh22+2 (7)2h2+2 (7) (4) 
